Caris Life Sciences (CAI) Preferred Dividend Payments (2024 - 2025)
Caris Life Sciences (CAI) recorded quarterly Preferred Dividend Payments of $384.4 million in Q2 2025, up 1471.56% quarter-over-quarter from $24.5 million in Q1 2025.
Caris Life Sciences (CAI) Preferred Dividend Payments (2024 - 2025) Analysis & Trends
Caris Life Sciences' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $384.4 million for Q2 2025.
- In Q2 2025, Preferred Dividend Payments changed N/A year-over-year to $384.4 million; the TTM figure through Mar 2026 stood at $384.4 million (up 164.24% YoY), while the FY2025 annual figure was $85.4 million, down 11.35% from the prior year.
- Preferred Dividend Payments was $384.4 million for Q2 2025 at Caris Life Sciences, up from $24.5 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $384.4 million in Q2 2025 to a low of $24.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 384.44 Mn |
| Mar 31, 2025 | 24.46 Mn |
| Dec 31, 2024 | 96.37 Mn |
| Sep 30, 2024 | 24.66 Mn |